Annals of Family Medicine

NOVEMBER 20, 2024

The ECHO (Extensions for Community Healthcare Outcomes) model is an ideal platform for dissemination of best practice guidelines and standards of care in common, complex, acute and chronic conditions. ECHO Concussion was launched in 2019 to teach clinicians a comprehensive approach to concussion diagnosis and management.

Management 130

Management Education Illness Chronic Condition 130

Annals of Family Medicine

NOVEMBER 20, 2024

Dataset: Administrative data from the Optum Labs Data Warehouse 2015-2019 that contains de-identified medical and pharmacy claims and eligibility information for commercial and Medicare Advantage enrollees in the US. Study Design: Retrospective cohort study.

Primary Care 130

Primary Care Management Utilities Chronic Condition 130

Canadian Family Physician

JUNE 16, 2025

We compared these populations to pre-pandemic analyses (2008, 2013, and 2019). Results After 2019, growth in the overall comprehensive FP workforce stagnated (2019: 9377; 2022: 9375). The oldest FP cohort (age ≥70) also increased in number and proportion in 2022.

Family Physician 52

Family Physician Families Family Patients 52

Annals of Family Medicine

NOVEMBER 20, 2024

These barriers may prevent TG from receiving the necessary care to address chronic conditions, such as cardiovascular disease (CVD). Setting or Dataset: Secondary analysis of the CDC state-specific Behavioral Risk Factor Surveillance System (BFRSS) surveys conducted from 2019 to 2022.

Relationship 130

Relationship Chronic Condition Individual Diabetes 130

GeriPal

MARCH 9, 2023

In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics.

Patient-Centered 91

Patient-Centered Community IT Medical 91

FDA Law

SEPTEMBER 13, 2021

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. The Plan supports legislative action to control total drug costs and patient out-of-pocket (“OOP”) costs for Medicare Part D beneficiaries.

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98